vs
NI Holdings, Inc.（NODK）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NI Holdings, Inc.的1.1倍（$69.8M vs $61.0M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -5.2%，领先389.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -17.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -9.5%）
NI Holdings, Inc.是一家总部位于美国的保险控股企业，核心业务为提供财产及意外伤害保险产品，覆盖个人车险、家庭财产险、小型商业保险等品类，服务美国多州的个人消费者及小微企业客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NODK vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.0M
营收增速更快
RIGL
高出38.7%
-17.5%
净利率更高
RIGL
高出389.2%
-5.2%
两年增速更快
RIGL
近两年复合增速
-9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.0M | $69.8M |
| 净利润 | $-3.2M | $268.1M |
| 毛利率 | 30.8% | 91.5% |
| 营业利润率 | -4.7% | 33.2% |
| 净利率 | -5.2% | 384.0% |
| 营收同比 | -17.5% | 21.2% |
| 净利润同比 | -132.0% | 1769.2% |
| 每股收益（稀释后） | $-0.16 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NODKRIGL
| Q4 25 | $61.0M | $69.8M | ||
| Q3 25 | $76.6M | $69.5M | ||
| Q2 25 | $76.1M | $101.7M | ||
| Q1 25 | $71.4M | $53.3M | ||
| Q4 24 | $73.9M | $57.6M | ||
| Q3 24 | $89.0M | $55.3M | ||
| Q2 24 | $87.8M | $36.8M | ||
| Q1 24 | $74.5M | $29.5M |
净利润NODKRIGL
| Q4 25 | $-3.2M | $268.1M | ||
| Q3 25 | $-1.7M | $27.9M | ||
| Q2 25 | $-12.1M | $59.6M | ||
| Q1 25 | $6.5M | $11.4M | ||
| Q4 24 | $9.8M | $14.3M | ||
| Q3 24 | $-2.7M | $12.4M | ||
| Q2 24 | $-19.6M | $-1.0M | ||
| Q1 24 | $6.4M | $-8.2M |
毛利率NODKRIGL
| Q4 25 | 30.8% | 91.5% | ||
| Q3 25 | 20.5% | 93.2% | ||
| Q2 25 | 8.4% | 95.6% | ||
| Q1 25 | 40.6% | 91.7% | ||
| Q4 24 | 52.7% | 89.9% | ||
| Q3 24 | 20.4% | 85.5% | ||
| Q2 24 | 18.0% | 92.4% | ||
| Q1 24 | 39.9% | 93.1% |
营业利润率NODKRIGL
| Q4 25 | -4.7% | 33.2% | ||
| Q3 25 | -2.4% | 40.9% | ||
| Q2 25 | -20.1% | 60.1% | ||
| Q1 25 | 10.8% | 23.9% | ||
| Q4 24 | 18.7% | 28.9% | ||
| Q3 24 | -3.9% | 25.4% | ||
| Q2 24 | -10.3% | 1.2% | ||
| Q1 24 | 11.9% | -23.6% |
净利率NODKRIGL
| Q4 25 | -5.2% | 384.0% | ||
| Q3 25 | -2.2% | 40.2% | ||
| Q2 25 | -15.8% | 58.6% | ||
| Q1 25 | 9.0% | 21.5% | ||
| Q4 24 | 13.3% | 24.9% | ||
| Q3 24 | -3.0% | 22.5% | ||
| Q2 24 | -22.3% | -2.8% | ||
| Q1 24 | 8.6% | -27.9% |
每股收益（稀释后）NODKRIGL
| Q4 25 | $-0.16 | $14.11 | ||
| Q3 25 | $-0.08 | $1.46 | ||
| Q2 25 | $-0.57 | $3.28 | ||
| Q1 25 | $0.31 | $0.63 | ||
| Q4 24 | $0.48 | $0.82 | ||
| Q3 24 | $-0.13 | $0.70 | ||
| Q2 24 | $-0.94 | $-0.06 | ||
| Q1 24 | $0.30 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.2M | $155.0M |
| 总债务越低越好 | $2.4M | $52.5M |
| 股东权益账面价值 | $240.3M | $391.5M |
| 总资产 | $506.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.01× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NODKRIGL
| Q4 25 | $52.2M | $155.0M | ||
| Q3 25 | $24.7M | $137.1M | ||
| Q2 25 | $56.8M | $108.4M | ||
| Q1 25 | $57.2M | $77.1M | ||
| Q4 24 | $51.4M | $77.3M | ||
| Q3 24 | $39.1M | $61.1M | ||
| Q2 24 | $51.4M | $49.1M | ||
| Q1 24 | $68.5M | $49.5M |
总债务NODKRIGL
| Q4 25 | $2.4M | $52.5M | ||
| Q3 25 | $2.4M | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $2.4M | $60.0M | ||
| Q3 24 | $2.4M | $60.0M | ||
| Q2 24 | $2.4M | $60.0M | ||
| Q1 24 | $2.4M | $60.0M |
股东权益NODKRIGL
| Q4 25 | $240.3M | $391.5M | ||
| Q3 25 | $243.8M | $117.6M | ||
| Q2 25 | $243.3M | $81.9M | ||
| Q1 25 | $254.0M | $18.6M | ||
| Q4 24 | $244.6M | $3.3M | ||
| Q3 24 | $241.4M | $-14.6M | ||
| Q2 24 | $236.1M | $-29.9M | ||
| Q1 24 | $255.8M | $-31.7M |
总资产NODKRIGL
| Q4 25 | $506.0M | $513.6M | ||
| Q3 25 | $543.8M | $242.5M | ||
| Q2 25 | $620.1M | $206.7M | ||
| Q1 25 | $525.4M | $176.0M | ||
| Q4 24 | $526.5M | $164.0M | ||
| Q3 24 | $559.9M | $139.4M | ||
| Q2 24 | $571.0M | $128.4M | ||
| Q1 24 | $674.5M | $126.5M |
负债/权益比NODKRIGL
| Q4 25 | 0.01× | 0.13× | ||
| Q3 25 | 0.01× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.01× | 18.25× | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NODKRIGL
| Q4 25 | $13.2M | $22.0M | ||
| Q3 25 | $-44.8M | $24.0M | ||
| Q2 25 | $6.4M | $30.5M | ||
| Q1 25 | $9.9M | $-893.0K | ||
| Q4 24 | $21.7M | $14.5M | ||
| Q3 24 | $-18.0M | $21.7M | ||
| Q2 24 | $18.1M | $302.0K | ||
| Q1 24 | $16.7M | $-5.0M |
自由现金流NODKRIGL
| Q4 25 | — | — | ||
| Q3 25 | $-44.8M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | $9.9M | — | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $-18.1M | — | ||
| Q2 24 | $17.5M | — | ||
| Q1 24 | $16.6M | — |
自由现金流率NODKRIGL
| Q4 25 | — | — | ||
| Q3 25 | -58.6% | — | ||
| Q2 25 | 8.2% | — | ||
| Q1 25 | 13.8% | — | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | -20.4% | — | ||
| Q2 24 | 20.0% | — | ||
| Q1 24 | 22.3% | — |
资本支出强度NODKRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.1% | — |
现金转化率NODKRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 1.53× | -0.08× | ||
| Q4 24 | 2.21× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
